Michael Chary MD, PhD

Emergency Medicine and Medical Toxicology Physician-Scientist at @WeillCornell @ED_WCMC @WCMEmergency

There is simply too much to think about

[ToxInTen @ToxInTen]

Happy Monday! The latest episode of Tox in Ten ACMT Highlights is live! @gillianbchum sits down with @macacharya to discuss the role of artificial intelligence in medical toxicology
@acmtmedtox https://t.co/mfsd4CxdRO

[American College of Medical Toxicology @acmtmedtox]

The best way to spend your Monday is listening to the newest @ToxInTen episode! @gillianbchum sits down with @macacharya to discuss the role of artificial intelligence in medical toxicology. #ToxTwitter #MedTwitter

[EAPCCT @eapcct]

Dear friends of @eapcct
This week #toxreadingcorner is on “The Role and Promise of Artificial Intelligence in Medical Toxicology” by Michael A. Chary et al. https://t.co/Vnz75tVwcc @macacharya @ManiniAlex @PEMTox

[EAPCCT @eapcct]

Toxicology 2.0 symposium, now speaking: The geospatial and linguistic dynamics of conversations on Twitter about vaping. Michael Chary (2020 -Abstract 099) #EAPCCT2021 @macacharya

[AIinHealthcare @AIinHealthcare]

.@macacharya @ToxInNewEngland: ‘A #transparentAI system may be useful by automating aspects [of] routine cases and in doing so freeing up expert time for more complicated cases’ of #overdose or #poisoning. #Toxicology #ExplainableAI https://t.co/xbvYHjOVv6

[Michael Chary MD, PhD @macacharya]

@eapcct Also related, our paper using probabilistic logical networks to diagnose toxidromes: https://t.co/rqRFP3AgA7
Sounds like a collab opportunity

[Brenna Farmer MD @BrennaFarmerMD]

Listening to my colleague Michael Chary MD PhD discuss AI in medical toxicology. #2021ACMT @acmtmedtox @WCMEmergency

[American College of Medical Toxicology @acmtmedtox]

#2021ACMT Happening now: @macacharya shines a light on the role artificial intelligence can play in medical toxicology during his 2:30 PM talk. @WeillCornell

[Michael Chary MD, PhD @macacharya]

@ManiniAlex @NYEmergency And, link to the ontology repository: https://t.co/pkTTRKPWRm

[Michael E Mullins @MikeMullinsMD]

Successful use of ECMO and lipid emulsion for massive bupropion overdose: a case report
https://t.co/YzLaADSrWH from @MikeEMPharmD @macacharya @philmoonsamy et al @MassGeneralNews Well documented #bupropion poisoning treated with #ECMO and ILE.

[Jeremy Faust MD MS (ER physician) @jeremyfaust]

Exposure To Other Coronaviruses Does Not Give Immunity Against SARS-CoV-2

https://t.co/hLigYFSInx via @Brief_19 @macacharya

[Jeremy Faust MD MS (ER physician) @jeremyfaust]

Here's the @Brief_19 Week in Review for COVID-19 research!

Take three minutes and catch up on the must know stories from the frontline this week.

Expertise from @angie_rasmussen @JPBelinkieMD @macacharya

https://t.co/CnSx9VJO6I via @Brief_19

[Michael Chary MD, PhD @macacharya]

@jeremyfaust @Brief_19 Information is everywhere. But, wisdom?

[Michael Chary MD, PhD @macacharya]

Check out my analysis on the new #modernavaccine trial. #CovidVaccine #COVID19

[Jeremy Faust MD MS (ER physician) @jeremyfaust]

In @Brief_19 later this AM:

✔️Analysis on the new Moderna trial. One dose? Promising but by no means ready for prime time. With @macacharya

✔️Will vaccine hesitancy lead to vaccine mandates? Schools will be a major battleground. @JPBelinkieMD explains.

https://t.co/4wRvUc85gS

[Michael Chary MD, PhD @macacharya]

Our latest paper in Toxicology Communications: Early intravenous lipid emulsion therapy for diphenhydramine overdose: a case report.
https://t.co/nZUO64xcH9

[Michael E Mullins @MikeMullinsMD]

Latest articles in Toxicology Communications (2/2):
Early intravenous lipid emulsion therapy for diphenhydramine overdose: a case report.
https://t.co/cBr3Dyh5YQ
From Clemons et al of @KendallRMC and @macacharya of
@WeillCornell @ED_WCMC @WCMEmergency

[Jeremy Faust MD MS (ER physician) @jeremyfaust]

Back in June, @macacharya wrote a brief on a small trial of colchicine in Covid-19 for @Brief_19.

The results were promising.

New findings publicized via press release (COLCORONA trial) are far too vague to be useful.

But here's what we do know...
👇
https://t.co/bWZ44SATE4

[Jeremy Faust MD MS (ER physician) @jeremyfaust]

Daily briefings from @Brief_19 return tomorrow AM!

This week: frontline expertise on the latest in Covid-19 medical research from @bernardchangMD @sampx @macacharya and @JPBelinkieMD.

Written by docs *for everyone*

Subscribe free and get it first! 🙌

https://t.co/4wRvUc85gS

[Jeremy Faust MD MS (ER physician) @jeremyfaust]

BinaxNOW Antigen Testing Can Be Used In Asymptomatic Individuals. Is It Ready For Prime Time?

First, we must ask the right question...

https://t.co/tG828BouKr via @Brief_19 @macacharya

[Brief19, your daily roundup of SARS-CoV-2. @Brief_19]

Abbott's new rapid antigen test, BinaxNOW, has received EUA from the @US_FDA.

@macacharya on a new @CDCgov study evaluating use in asymptomatic individuals & what this means:

https://t.co/30w4a9Kq0U

[Michael Chary MD, PhD @macacharya]

Check out my summary of the #Covid_19 @moderna_tx #vaccine ! @NEJM

[Brief19, your daily roundup of SARS-CoV-2. @Brief_19]

<Breaking>

Moderna vaccine trial has been published.

Our immediate analysis here, with updates in our AM briefing.

https://t.co/n5xEE4hy4c via @Brief_19 @macacharya